Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 238
Filter
1.
JBJS Rev ; 10(10)2022 10 01.
Article in English | MEDLINE | ID: mdl-36326720

ABSTRACT

BACKGROUND: A radiographic fat pad sign after an elbow injury in children may indicate an occult fracture. Different incidences and locations of occult fractures have been reported. The primary objective of this meta-analysis was to assess the overall rate of occult fractures in children with a positive fat pad sign from the data of original studies. Secondary objectives were to assess the fracture types and to identify risk factors for sustaining an occult fracture. METHODS: A systematic literature search of the Embase, MEDLINE, and Cochrane databases was performed according to PRISMA guidelines. Studies on pediatric populations with a positive fat pad sign identified using a lateral elbow radiograph and with follow-up imaging were included in this meta-analysis. Included studies were assessed for risk of bias with use of the MINORS (Methodological Index for NOn-Randomized Studies) instrument. RESULTS: Ten studies with a total of 250 patients, of whom 104 had an occult fracture, were included. Accounting for heterogeneity between the studies, the overall occult fracture rate was 44.6% (95% confidence interval: 30.4% to 59.7%). The most common fracture locations were the supracondylar humerus (43%), proximal ulna (19%), proximal radius (17%), and lateral humeral condyle (14%). Definitions of a positive pad fad sign were not uniform among studies, and the follow-up imaging modality also varied (radiography, magnetic resonance imaging, or computed tomography). The average MINORS score was 10.1 for the 7 noncomparative studies and 18.7 for the 3 comparative studies, with both averages classified as moderate quality. We were not able to identify risk factors for an occult fracture in the presence of a positive fat pad sign. CONCLUSIONS: The occult fracture rate was 44.6% in pediatric elbow injuries with a positive fat pad sign. Supracondylar humeral fractures were the most frequently encountered type. The findings of this meta-analysis underline the potential clinical relevance of a positive fat pad sign in children and denote the opportunity for future studies to create evidence-based guidelines. LEVEL OF EVIDENCE: Level II. See Instructions for Authors for a complete description of levels of evidence.


Subject(s)
Elbow Injuries , Elbow Joint , Fractures, Closed , Humeral Fractures , Humans , Child , Fractures, Closed/diagnosis , Fractures, Closed/pathology , Elbow/diagnostic imaging , Elbow Joint/diagnostic imaging , Humeral Fractures/diagnostic imaging , Adipose Tissue
2.
Ann Vasc Surg ; 60: 270-278.e2, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31077770

ABSTRACT

BACKGROUND: Delirium in patients with critical limb ischemia (CLI) is associated with increased mortality. The main goal of this study was to investigate the association between delirium and mortality in patients undergoing major lower limb amputation for CLI. In addition, other risk factors associated with mortality were analyzed. METHODS: An observational cohort study was conducted including all patients aged ≥70 years with CLI undergoing a major lower limb amputation between January 2014 and July 2017. Delirium was scored using the Delirium Observation Screening Score in combination with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Risk factors for mortality were analyzed by calculating hazard ratios using a Cox proportional hazards model. RESULTS: In total, 95 patients were included; of which, 29 (31%) patients developed a delirium during admission. Delirium was not associated with an increased risk of mortality (hazard ratio [HR] = 0.84; 95 % confidence interval [CI]: 0.51-1.73; P = 0.84). Variables independently associated with an increased risk of mortality were age (HR 1.1; 95% CI 1.0-1.1), cardiac history (HR 3.3; 95% CI 1.8-6.1), current smoking (HR 2.9; 95% CI 1.6-5.5), preoperative anemia (HR 2.8; 95% CI 1.1-7.2), and living in a nursing home (HR 2.2; 95% CI 1.1-4.4). CONCLUSION: Delirium was not associated with an increased mortality risk in elderly patients with CLI undergoing a major lower limb amputation. Factors related to an increased mortality risk were age, cardiac history, current smoking, preoperative anemia, and living in a nursing home.


Subject(s)
Amputation, Surgical/mortality , Delirium/mortality , Ischemia/surgery , Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Age Factors , Aged , Aged, 80 and over , Amputation, Surgical/adverse effects , Critical Illness , Delirium/diagnosis , Delirium/psychology , Female , Humans , Incidence , Ischemia/diagnostic imaging , Ischemia/mortality , Ischemia/physiopathology , Male , Peripheral Arterial Disease/diagnostic imaging , Peripheral Arterial Disease/mortality , Peripheral Arterial Disease/physiopathology , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome
3.
HIV Med ; 16(2): 122-31, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25472825

ABSTRACT

OBJECTIVES: The aim of the study was to test the antiviral efficacy of a triple nucleoside reverse transcriptase inhibitor (NRTI) regimen, with potential beneficial metabolic effects, as maintenance therapy after induction with dual NRTIs and a boosted protease inhibitor (PI). METHODS: An open-label, noninferiority study was carried out. Antiretroviral therapy (ART)-naïve patients with CD4 count ≤ 350 cells/µL and HIV-1 RNA >30000 copies/mL (n=207) were treated with zidovudine/lamivudine and lopinavir/ritonavir. After achieving HIV-1 RNA <50 copies/mL on two consecutive occasions between weeks 12 and 24 after baseline, 120 patients (baseline: median HIV-1 RNA 5.19 log10 copies/mL; median CD4 count 180 cells/µL) were randomized to receive abacavir/lamivudine/zidovudine (ABC/3TC/ZDV) (n=61) or to continue the PI-based ART (n=59). RESULTS: For the proportions of patients (intention-to-treat; missing=failure) with HIV-1 RNA <400 copies/mL (PI group, 66%; ABC/3TC/ZDV group, 71%) and <50 copies/mL (PI group, 63%; ABC/3TC/ZDV group, 62%) at 96 weeks, switching to ABC/3TC/ZDV was noninferior compared with continuing the PI regimen; the difference in failure rate (ABC/3TC/ZDV minus PI) was -4.4 percentage points [95% confidence interval (CI) -21.0 to +12.3 percentage points] and +0.4 percentage points (95% CI -16.9 to +17.7 percentage points), respectively. In the per protocol analysis, the difference in virological failure for HIV-1 RNA >400 copies/mL (0 of 39 patients in the PI group and two of 45 patients in the NRTI group) and for HIV-1 RNA >50 copies/mL (two of 39 and three of 45 patients, respectively) was +4.4 percentage points (95% CI -2.1 to +11.0 percentage points) and +1.5 percentage points (95% CI -8.6 to +11.7 percentage points), respectively, also showing noninferiority. Serum lipids significantly improved in the NRTI group, but not in the PI arm. CONCLUSIONS: A single-class NRTI regimen after successful induction with standard ART had similar antiviral efficacy compared to continuation of a PI-based regimen at 96 weeks after baseline, with improved serum lipids.


Subject(s)
Anti-HIV Agents/administration & dosage , Dideoxynucleosides/administration & dosage , HIV Infections/drug therapy , Lamivudine/administration & dosage , Zidovudine/administration & dosage , Adult , Aged , Belgium/epidemiology , CD4 Lymphocyte Count , Clinical Protocols , Disease Progression , Drug Administration Schedule , Drug Combinations , Drug Therapy, Combination , Female , HIV Infections/immunology , HIV Protease Inhibitors , HIV-1/immunology , Humans , Lipids , Male , Middle Aged , Netherlands/epidemiology , Prospective Studies , RNA, Viral/drug effects , Treatment Outcome , Viral Load
4.
J Econ Entomol ; 106(2): 1071-4, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23786103

ABSTRACT

A no-choice test was performed to determine survival and reproductive capacity of stored-product insect pests on pecan, Carya illinoensis (Wangenheim) Koch. Insects used were Indianmeal moth, Plodia interpunctella (Hübner) (Lepidoptera: Pyralidae); sawtoothed grain beetle, Oryzaephilus surinamensis (L.) (Coleoptera: Cucujidae); red flour beetle, Tribolium castaneum (Herbst) (Coleoptera: Tenebrionidae); lesser grain borer, Rhyzopertha dominica (F.) (Coleoptera: Bostrichidae); and rusty grain beetle, Cryptolestes ferrugineus (Stephens) (Coleoptera: Laemophloeidae). Fifty adults of each beetle species or 10 reproductive pairs of P. interpunctella adults were placed in 0.5-liter containers with either whole-shell pecans, cracked-shell pecans, randomly selected in-shell pecans, pecan nutmeats, cracked wheat, or glass beads and held at 28 degrees C, 60-70% relative humidity, and 16:8 (L:D) photoperiod for 2, 4, 6, and 8 wk. Four replications of each insect-diet-interval combination were performed. Larvae of P. interpunctella, O. surinamensis, T. castaneum, C. ferrugineus, and adult P. interpunctella and O. surinamensis developed on cracked and nutmeat pecan diets. R. dominica did not complete reproduction on pecans. Knowledge that these pests can reproduce on stored pecan will assist pecan growers, accumulators, and storage facilities in preventing insect outbreaks on their product.


Subject(s)
Carya/physiology , Coleoptera/physiology , Moths/physiology , Animals , Feeding Behavior , Nuts/physiology , Reproduction , Time Factors
5.
Eur J Vasc Endovasc Surg ; 40(5): 635-42, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20667751

ABSTRACT

OBJECTIVE: To investigate the efficacy of A-V impulse technology (A-V) for oedema prevention and treatment following PTFE femoropopliteal surgery. DESIGN: Prospective randomized clinical trial. MATERIALS: 36 patients undergoing PTFE femoropopliteal bypass reconstructions, either being treated postoperatively with a compression stocking (CS) (Group-1, n = 19) or with A-V (Group-2, n = 17). METHODS: Patients in treatment group-1 used a CS postoperatively during 1 week day and night, patients in group-2 were treated with A-V postoperatively at night during one week. The lower leg circumference was measured preoperatively and at five postoperative time points. RESULTS: Limb circumference has increased postoperatively on day 1 (CS 1.5%/A-V 1.4%), on day 4 (5.7%/6.3%), on day 7 (6.6%/6.1%), on day 14 (7.9%/7.7%) and on day 90 (5.8%/5.2%). Differences between treatment groups were not significant. A re-operation gives a significant 3.9% increase in circumference as compared to a first operation (95% CI: 1.5-6.4%; p = 0.002). CONCLUSION: No significant differences were found in the extent of developed edema between the groups following PTFE femoropopliteal bypass surgery. A redo peripheral bypass operation results in significantly more postoperative oedema than a first-time performed bypass operation.


Subject(s)
Blood Vessel Prosthesis Implantation/adverse effects , Edema/therapy , Intermittent Pneumatic Compression Devices , Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Adult , Aged , Aged, 80 and over , Biocompatible Materials , Edema/etiology , Female , Femoral Artery/surgery , Humans , Lower Extremity/surgery , Male , Middle Aged , Polytetrafluoroethylene , Popliteal Artery/surgery , Prospective Studies , Reoperation , Stockings, Compression
6.
Aliment Pharmacol Ther ; 31(1): 150-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19785625

ABSTRACT

BACKGROUND: Esomeprazole and pantoprazole are metabolized in the liver and the polymorphic CYP2C19 enzyme is involved in that process. This genetic polymorphism determines fast (70% of Caucasians), intermediate (25-30% of Caucasians) and slow (2-5% of Caucasians) metabolism of PPIs. AIM: To compare the acid-inhibitory effects of esomeprazole 40 mg and pantoprazole 40 mg at 4, 24 and 120 h after oral administration in relation to CYP2C19 genotype and pharmacokinetics. METHODS: CYP2C19*2, *3, *4, *5 and *17 genotypes were determined in healthy Helicobacter pylori-negative Caucasian subjects. 7 wt/wt, 7 wt/*2, 2 wt/*17, 2 *2/*17 and 1 *2/*2 were included in a randomized investigator-blinded cross-over study with esomeprazole 40 mg and pantoprazole 40 mg. Intragastric 24-h pH-monitoring was performed on days 0, 1 and 5 of oral dosing. RESULTS: A total of 19 subjects (mean age 24 years, 7 male) completed the study. At day 1 and 5, acid-inhibition with esomeprazole was significantly greater and faster than with pantoprazole. Differences in acid-inhibition and pharmacokinetics between wt/wt and wt/*2 genotype were significant for pantoprazole at day 1 and 5. CONCLUSIONS: Esomeprazole provides acid-inhibition faster than and superior to pantoprazole after single and repeated administration. The acid-inhibitory effect and the kinetics of pantoprazole are influenced by CYP2C19 genotype.


Subject(s)
2-Pyridinylmethylsulfinylbenzimidazoles/pharmacokinetics , Anti-Ulcer Agents/pharmacokinetics , Aryl Hydrocarbon Hydroxylases/drug effects , Esomeprazole/pharmacokinetics , Gastric Acid/metabolism , Helicobacter Infections/metabolism , 2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage , Adolescent , Adult , Anti-Ulcer Agents/administration & dosage , Aryl Hydrocarbon Hydroxylases/genetics , Cytochrome P-450 CYP2C19 , Esomeprazole/administration & dosage , Female , Gastric Acidity Determination , Genotype , Helicobacter Infections/genetics , Helicobacter pylori , Humans , Male , Monitoring, Physiologic , Pantoprazole , Polymorphism, Genetic/drug effects , Time Factors , Treatment Outcome , Young Adult
7.
J Psychopharmacol ; 24(4): 497-502, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19423613

ABSTRACT

The present study investigated the influence of gender and menopausal status on treatment response in depressed inpatients, treated with either imipramine or fluvoxamine. The patients were divided into three groups: men, premenopausal women and postmenopausal women. A multivariate analysis was performed using the difference in Hamilton score (pretreatment - post-treatment) for imipramine and fluvoxamine as dependent variable. The following independent variables were used: the baseline Hamilton score, the antidepressant used, the gender-group and the interaction between the type of antidepressant and gender. In total, 138 patients with a DSM IV diagnosis of depressive disorder were analysed. Men responded more favorably to imipramine (B = 7.12, P = 0.005). Premenopausal women had a better response rate to fluvoxamine than men (B = -8.66, P = 0.027). In depressed inpatients, men respond more favorably to imipramine than to fluvoxamine. Premenopausal women respond more frequently to fluvoxamine than men.


Subject(s)
Antidepressive Agents/therapeutic use , Depressive Disorder/drug therapy , Fluvoxamine/therapeutic use , Imipramine/therapeutic use , Inpatients , Menopause/psychology , Adult , Aged , Depressive Disorder/diagnosis , Depressive Disorder/psychology , Double-Blind Method , Female , Humans , Linear Models , Male , Middle Aged , Netherlands , Psychiatric Status Rating Scales , Sex Factors , Single-Blind Method , Surveys and Questionnaires , Treatment Outcome , Young Adult
8.
J Psychopharmacol ; 24(4): 559-63, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19028834

ABSTRACT

Depression and anxiety frequently occur together or in extension of each other. According to a previous study in depressed inpatients, a high trait anxiety level correlated with a positive response to the diazepam test (DT) and a low trait anxiety level with a negative response to the test. The aim of this study is to investigate whether positive reaction to the DT is related to a positive response to fluvoxamine and whether a negative reaction to the test is related to positive response to imipramine. The DT was performed in 130 patients diagnosed with a depressive disorder. Following the DT, the patients were randomly assigned to double-blind treatment with either imipramine or fluvoxamine. Doses of both antidepressants were adjusted to attain predefined blood levels, and the outcome was evaluated 4 weeks after attaining these blood levels. Twenty-two patients had a positive response to the DT, whereas 108 patients had a negative response. Although a positive DT is correlated with a high level of trait anxiety, no differences in depressive symptomatology and antidepressant response were found between patients with a positive and a negative DT.


Subject(s)
Antidepressive Agents/therapeutic use , Anxiety/epidemiology , Depressive Disorder/drug therapy , Fluvoxamine/therapeutic use , Imipramine/therapeutic use , Inpatients , Adult , Aged , Antidepressive Agents/blood , Anxiety/diagnosis , Anxiety/psychology , Depressive Disorder/diagnosis , Depressive Disorder/epidemiology , Depressive Disorder/psychology , Diazepam , Double-Blind Method , Female , Fluvoxamine/blood , Humans , Imipramine/blood , Male , Middle Aged , Netherlands/epidemiology , Predictive Value of Tests , Prevalence , Psychiatric Status Rating Scales , Severity of Illness Index , Time Factors , Treatment Outcome
9.
Tijdschr Psychiatr ; 51(5): 279-89, 2009.
Article in Dutch | MEDLINE | ID: mdl-19434565

ABSTRACT

BACKGROUND: Culture can have a considerable influence on the way in which a depression is experienced, expressed or presented. Strict Calvinists or reformed pietists form an orthodox protestant cultural minority in the Netherlands. This orthodox wing of the Dutch Reformed Churches places a strong emphasis on personal religious experience of God's work of conversion. It is possible that symptoms of depression in this group differ somewhat from such symptoms in nonaffiliated depressed patients. AIM: To determine whether depressive symptoms in strict Calvinistic patients differ from those in non-affiliated patients. METHOD: Seventy depressed adult Dutch nationals receiving treatment as outpatients under the mental health service were asked to fill in a depression self-scoring list (Beck Depression Inventory II (bdi-ii)). A comparison was made between the total scores and scores of symptom clusters of strict Calvinists and the corresponding scores of non-affiliated patients. results The strict Calvinists had a lower total score than the non-affiliated patients on the bdi-ii and their scores were particularly lower for the symptom clusters suicidality and restrictions in functioning. CONCLUSION: Strict Calvinists differed from the non-affiliated patients in the way in which they presented on a depression self scoring list during depression. Perhaps strict Calvinists have less chance of being diagnosed and treated at an early stage because they conceal their depression and struggle on for a longer time. The study shows that insight into the religious background of Dutch national patients can be important for accurate psychiatric diagnostics.


Subject(s)
Depressive Disorder/diagnosis , Depressive Disorder/psychology , Religion and Psychology , Adolescent , Adult , Aged , Case-Control Studies , Depressive Disorder/epidemiology , Female , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Severity of Illness Index , Surveys and Questionnaires , Young Adult
10.
Cleft Palate Craniofac J ; 46(2): 147-53, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19254052

ABSTRACT

OBJECTIVE: To investigate the reliability of length measurements of the mandible by comparing orthopantomograms (OPTs) with lateral cephalograms. DESIGN: Observational study. SETTING: OPTs and lateral cephalograms were taken of 20 human dry skulls. Four orthodontists and four maxillofacial surgeons located landmarks on all radiographs using a computer program for cephalometric measurements. Intraobserver and interobserver variability in locating landmarks was assessed, as well as positioning of the skulls prior to radiography between the x-ray assistants. Magnification differences between the left and right side of the mandible on the OPT were determined for five skulls. Kappa statistics were used to calculate the intraclass correlation coefficient for intraobserver and interobserver differences. An F test was used to assess differences between methods and between type of observer. RESULTS: No significant differences were found in the magnification factor of the left and right side of the mandible. Compared with a lateral cephalogram, the OPT had comparable reliability in measuring mandibular distances condylion-gonion, gonion-menton, and condylion-menton. No significant differences were observed between the x-ray assistants in taking the OPTs and lateral cephalograms or in repositioning the skulls. Significant differences were found between orthodontists and maxillofacial surgeons for landmark measurements. CONCLUSION: An OPT is as reliable as a lateral cephalogram for linear measurements of the mandible (condylion-gonion, gonion-menton, and condylion-menton).


Subject(s)
Cephalometry/statistics & numerical data , Mandible/diagnostic imaging , Radiography, Panoramic/statistics & numerical data , Chin/diagnostic imaging , Humans , Image Processing, Computer-Assisted , Mandibular Condyle/diagnostic imaging , Observer Variation , Orthodontics/statistics & numerical data , Radiographic Magnification/statistics & numerical data , Reproducibility of Results , Software , Surgery, Oral/statistics & numerical data
11.
Clin Endocrinol (Oxf) ; 70(2): 265-73, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19200215

ABSTRACT

BACKGROUND: Besides short stature, gonadal dysgenesis leading to a lack of oestrogen is one of the main characteristics of Turner syndrome (TS). In most TS girls, puberty is induced with exogenous oestrogens. OBJECTIVE: To describe the pubertal development and uterine dimensions achieved by low-dose 17beta-oestradiol (17beta-E2) orally started at an appropriate age. Additionally, to determine whether serum hormone levels aid evaluation of pubertal progression. DESIGN: In 56 TS girls, we prospectively studied pubertal stage, serum E2, LH, FSH, SHBG and oestrone (E1), starting oestrogen treatment with a low-dose 17beta-E2 (5 microg/kg/day) during GH treatment at mean (SD) age 12.7 (0.7) years. Hormone levels were measured at start, 3 months after start and after increasing 17beta-E2 dosage. Uterine dimensions were measured in 39 TS women at age 19.9 (2.2) years. RESULTS: Although breast and pubic hair development were similar to that in normal Dutch girls up to Tanner stage B5 and P5, respectively, breast development was 2 years later. Before oestrogen therapy, E2 levels were comparable to those in prepubertal girls. With a 17beta-E2 dose of 5 microg/kg/day, these levels increased significantly, becoming comparable to normal late pubertal or adult concentrations, whereas SHBG levels were unchanged. At the adult 17beta-E2 dose, SHBG had increased significantly. Uterus shape was juvenile in four (10.2%), cylindrical in four and mature-adult shaped in 31 (79.5%) of TS patients. CONCLUSIONS: During GH treatment in TS girls, normal breast development up to B5 can be mimicked, with just a 2-year delay. In a clinical setting, serum hormone levels provide no additional information for evaluating pubertal progression. After age-appropriate pubertal induction, uterine dimensions in women aged nearly 20 years were subnormal. It remains unclear whether this was related to E2 dosage, timing or duration, or factors related to TS.


Subject(s)
Estrogens/blood , Estrogens/pharmacology , Puberty/drug effects , Sex Characteristics , Turner Syndrome/metabolism , Turner Syndrome/pathology , Uterus/pathology , Administration, Oral , Adolescent , Breast/drug effects , Breast/growth & development , Child , Cross-Sectional Studies , Dose-Response Relationship, Drug , Estradiol/administration & dosage , Estradiol/pharmacology , Estradiol/therapeutic use , Estrogens/administration & dosage , Estrone/blood , Female , Follicle Stimulating Hormone/blood , Follow-Up Studies , Humans , Luteinizing Hormone/blood , Prospective Studies , Sex Hormone-Binding Globulin/metabolism , Turner Syndrome/drug therapy , Uterus/drug effects , Young Adult
12.
Pediatr Allergy Immunol ; 20(1): 53-8, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18627510

ABSTRACT

In recent years, the atopy patch test (APT) has been suggested as an addition in the allergological work-up of children with atopic dermatitis (AD) and suspected food allergy. We initiated a prospective clinical study in children with AD younger than 3 yr, to evaluate the additional clinical value of the APT next to our own standardized allergological work-up in case of a suspected food allergy. One hundred and thirty-five children were included in the study. They were tested using the skin application food test (SAFT), the APT and measurement of specific IgE. The allergens used in the skin tests were freshly prepared food stuffs and included commercially available cow's milk (CM), the egg white of a hard boiled hen's egg and mashed peanuts in a saline solution. Allergy was defined using a flowchart incorporating the results from the SAFT, oral challenges (OCs) and elimination and (re)introduction periods. To determine the additional value of the APT next to the SAFT, we analyzed the SAFT negative patients per allergen and used an exact binary logistic analysis to evaluate the simultaneous effects of the APT and measurement of specific IgE, calculating mutually adjusted odds ratios (ORs) for positive APTs and specific IgE levels above 0.70 U/l. We found clinically relevant food allergies in 23% (egg white) to 28% (CM and peanut) of our study population. Positive SAFT reactions were observed in 14% (peanut), 16% (egg white) and 21% (CM) of our patient population. Next to the SAFT, we did not observe a significant additional value of the APT for the diagnosis of CM or egg white allergy, but we did find a significant additional value for the diagnosis of peanut allergy (OR = 11.56; p < 0.005, 2-sided). In clinical practice this statistically significant value does not exclude the need for OC and controlled elimination and (re)introduction periods due to the presence of false-negative as well as false-positive results in the APT. In conclusion, we could not find enough support for the current addition of the APT to our standardized allergological work-up in young children below the age of 3 yr with AD and suspected food allergy. At the moment the additional value of the classical delayed-type APT next to the SAFT seems to be very limited at best in this study population and does not justify the time-consuming nature of the skin test.


Subject(s)
Allergens/immunology , Dermatitis, Atopic/diagnosis , Food Hypersensitivity/diagnosis , Patch Tests/standards , Animals , Arachis/immunology , Child, Preschool , Dermatitis, Atopic/immunology , Egg Proteins/immunology , False Positive Reactions , Food Hypersensitivity/immunology , Humans , Hypersensitivity, Delayed/diagnosis , Hypersensitivity, Delayed/immunology , Hypersensitivity, Immediate/diagnosis , Hypersensitivity, Immediate/immunology , Immunoglobulin E/blood , Infant , Infant, Newborn , Milk/immunology , Prospective Studies
13.
J Psychopharmacol ; 23(6): 708-13, 2009 Aug.
Article in English | MEDLINE | ID: mdl-18562424

ABSTRACT

With respect to the pharmacological characteristic, venlafaxine is comparable with tricyclic antidepressants (TCAs), and venlafaxine might be comparable in efficacy. We performed a systematic review investigating the relative efficacy and tolerability of venlafaxine compared with TCAs (imipramine, clomipramine, amitriptyline, nortriptyline and desipramine). Relevant double-blind randomised trials were identified from systematic searches of electronic databases. An exact analysis of the estimated odds ratios of response of the TCA relative to venlafaxine showed no overall significance of treatment effect (P = 0.38). The odds ratios were not homogenous across studies (P = 0.0213). The average dose of venlafaxine was 103.5 mg/day and for the TCA 106.1 mg/day. An exact analysis of the estimated odds ratios of the withdrawals and side effects in the trials with a TCA relative to venlafaxine showed no overall significance of withdrawal. From our review, no significant difference in treatment effect between low dose of both venlafaxine and the TCAs could be found. In our opinion, because of the heterogeneity of the odds ratios, one cannot conclude that they are of equal efficacy.


Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , Antidepressive Agents, Tricyclic/therapeutic use , Cyclohexanols/therapeutic use , Depressive Disorder/drug therapy , Antidepressive Agents, Second-Generation/adverse effects , Antidepressive Agents, Tricyclic/adverse effects , Cyclohexanols/adverse effects , Depressive Disorder/psychology , Humans , Odds Ratio , Randomized Controlled Trials as Topic , Research Design , Treatment Outcome , Venlafaxine Hydrochloride
14.
Osteoporos Int ; 20(8): 1347-52, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19039511

ABSTRACT

SUMMARY: In women older than 60 years with clinical risk factors for osteoporosis but without osteoporosis based on bone mineral density (T-score >or= -2.5), a systematic survey with X-rays of the spine identified previously unknown vertebral deformities in 21% of women. INTRODUCTION: This study determines the prevalence of vertebral deformities in elderly women with clinical risk factors for osteoporosis but with BMD values above the threshold for osteoporosis (T-score >or= -2.5). METHODS: Bisphosphonate naïve women older than 60 years attending 35 general practices in the Netherlands with >or=2 clinical risk factors for osteoporosis were invited for BMD measurement (DXA). In women with T-score >or= -2.5 at both spine and the hips, lateral radiographs of the thoracic and lumbar spine were performed. RESULTS: Of 631 women with a DXA measurement, 187 (30%) had osteoporosis (T-score < -2.5 at the spine or the hip). Of the remaining 444 women with T-score >or= -2.5 at both spine and hip, 387 had additional spine radiographs, of whom 80 (21%) had at least one vertebral deformity. CONCLUSION: In elderly women with clinical risk factors for osteoporosis but BMD T-score >or= -2.5, addition of spine radiographs identified vertebral deformities in 21% (95% CI: 17-25). Since these women are at risk of future fractures, antiosteoporotic treatment should be considered.


Subject(s)
Osteoporosis, Postmenopausal/diagnostic imaging , Spinal Curvatures/diagnostic imaging , Spinal Fractures/diagnostic imaging , Absorptiometry, Photon , Aged , Aged, 80 and over , Bone Density , False Negative Reactions , Female , Humans , Middle Aged , Osteoporosis, Postmenopausal/complications , Osteoporosis, Postmenopausal/physiopathology , Patient Selection , Prospective Studies , Risk Factors , Spinal Curvatures/etiology , Spinal Curvatures/physiopathology , Spinal Fractures/etiology , Spinal Fractures/physiopathology
15.
Clin Exp Dermatol ; 34(4): 462-8, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19077102

ABSTRACT

BACKGROUND: Skin lesions are the predominant clinical feature of the commonest form of mastocytosis. Mastocytosis is classified according to World Health Organization criteria. Determination of the levels of mast-cell mediators or their metabolites reflects the mast-cell burden. The extent of cutaneous mastocytosis can be assessed clinically using a scoring system (SCORing MAstocytosis; SCORMA Index) that we have developed. OBJECTIVE: Serum tryptase levels were compared with the SCORMA Index in a large group of paediatric and adult patients to investigate whether there was any correlation between the two. METHODS: The SCORMA Index in 64 patients (31 children and 33 adults) was compared with serum tryptase levels. The results of the first visit at which SCORMA and tryptase were evaluated were analysed. RESULTS: There was a positive correlation between the SCORMA Index and serum tryptase levels, indicating the value of the SCORMA Index in the assessment of mastocytosis with skin involvement. CONCLUSION: The results of this study showed that the SCORMA Index is a useful tool for evaluating the severity of cutaneous mastocytosis. The correlation between the SCORMA Index and serum tryptase levels underlines the benefit of the SCORMA Index as a clinical tool. Repeated SCORMA Index measurements can provide a rapid impression of changes in the clinical state of mastocytosis. This is particularly relevant in children, because taking blood samples from this group is much more difficult. The well-established methods for evaluation of disease severity may be expanded by the rapid SCORMA Index method.


Subject(s)
Mastocytosis, Cutaneous/enzymology , Mastocytosis, Cutaneous/pathology , Tryptases/blood , Urticaria Pigmentosa/pathology , Adolescent , Adult , Age of Onset , Aged , Biomarkers/blood , Child , Child, Preschool , Disease Progression , Female , Humans , Infant , Infant, Newborn , Male , Mast Cells/enzymology , Mast Cells/pathology , Mastocytosis, Cutaneous/genetics , Middle Aged , Prognosis , Severity of Illness Index , Urticaria Pigmentosa/enzymology , Urticaria Pigmentosa/genetics , Young Adult
16.
Br J Ophthalmol ; 92(12): 1676-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18772179

ABSTRACT

AIM: To introduce a new floating device for donor corneas to avoid accumulation of debris onto the endothelial surface during organ culture and to facilitate handling of the tissue during preservation and surgery. METHODS: From 11 donors, one randomly chosen cornea was stored in organ culture attached to a floating device, while the contralateral cornea was attached to the lid of the phial by a suture ("hanging by suture"). Endothelial cell density (ECD) was evaluated prior to tissue storage and after 2-3 weeks of culture. Furthermore, we compared ECD in a larger group of corneas sent off for transplantation with the device (n = 281) to a historical group of control corneas "hanging by suture" (n = 444). RESULTS: There was no significant difference in ECD between corneas attached to the floating device or "hanging by suture" (n = 11; p > or = 0.1). Similarly, no different ECDs were observed between corneas sent off for transplantation with the device (n = 281) and the historical group of control corneas "hanging by suture" (n = 444) (p > or = 0.1). CONCLUSION: The use of the floating device may not affect tissue quality. Since its introduction, the use of the device has been uneventful and greatly facilitated tissue handling.


Subject(s)
Cornea/cytology , Organ Culture Techniques/instrumentation , Organ Preservation/instrumentation , Aged , Endothelium, Corneal/cytology , Female , Humans , Male , Organ Preservation Solutions , Sutures , Time Factors
18.
Br J Ophthalmol ; 92(9): 1195-200, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18617539

ABSTRACT

AIM: Recent phylogenetic analyses on the herpes simplex virus type 1 (HSV-1) genes US4, encoding glycoprotein G (gG) and US7, encoding gI, of clinical HSV-1 isolates have led to the classification of HSV-1 into three genotypes, arbitrarily designated as A, B and C. The prevalence of the HSV-1 gG and gI genotypes and their potential disease association was determined in a large cohort of patients with herpetic keratitis (HK). METHODS: Primary corneal HSV-1 isolates of 178 HK patients were genotyped by a PCR-based restriction fragment length polymorphism method targeting the viral genes US4 and US7. RESULTS: Genotype B was more frequently expressed by the corneal HSV-1 isolates compared with genotypes A and C. Fifty-five of 178 corneal isolates (31%) had different genotypes in both loci. No clinically relevant associations were observed between the HSV-1 genotypes and disease outcome in the HK patients studied. CONCLUSIONS: The data presented demonstrate a high frequency of recombinant corneal HSV-1 isolates and suggest that clinical outcome of HSV-1-induced keratitis is independent of a gG or gI genotype.


Subject(s)
Herpesvirus 1, Human/genetics , Keratitis, Herpetic/virology , Viral Envelope Proteins/genetics , Aged , Cohort Studies , DNA, Viral/genetics , DNA, Viral/isolation & purification , Female , Genotype , Herpesvirus 1, Human/classification , Humans , Male , Middle Aged , Netherlands , Polymorphism, Restriction Fragment Length , Viral Envelope Proteins/analysis
19.
Tijdschr Psychiatr ; 50(4): 205-15, 2008.
Article in Dutch | MEDLINE | ID: mdl-18398800

ABSTRACT

BACKGROUND: When patients with cardiovascular disorders undergo electroconvulsive therapy (ect) they sometimes have to be treated for tachycardia and high blood pressure. AIM: To describe the effects of beta-blockers on seizure duration and cardiovascular variables in patients undergoing ect. METHOD: Search for studies in Medline, with the keywords 'beta-adrenergic blocking agents' and 'electroconvulsive therapy'. Only articles based on randomised placebo-controlled investigations were included. results The search strategy produced 21 articles. These were assessed by all authors. Esmolol was the drug administered in most of the trials. Since seizure duration can influence the therapeutic effect of ect it is advisable to use bilateral electrode placement in patients with cardiovascular risk factors and to administer esmolol prior to seizure induction. CONCLUSION: The beta-blocker of choice for use during ect seems to be esmolol; it can shorten seizure duration, although the effect is probably dose-dependent. Esmolol is also the drug of choice in ect sessions for patients without cardiovascular risk factors but who develop prolonged hypertension or tachycardia. A possible alternative is labetalol, but its longer half-life is a disadvantage, particularly if it is administered in a high dose. So far, experience with landiolol is limited, but its short half-life, greater cardioselectivity and higher potency mean that it could be a promising alternative.


Subject(s)
Adrenergic beta-Antagonists/administration & dosage , Electroconvulsive Therapy , Seizures/prevention & control , Blood Pressure/drug effects , Cardiovascular Diseases/complications , Dose-Response Relationship, Drug , Heart Rate/drug effects , Humans , Propanolamines/administration & dosage , Randomized Controlled Trials as Topic , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...